Literature DB >> 16969497

Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms.

Naohito Urawa1, Yoshinao Kobayashi, Jun Araki, Ryosuke Sugimoto, Motoh Iwasa, Masahiko Kaito, Yukihko Adachi.   

Abstract

UDP-glucuronosyltransferase (UGT) enzymes are responsible for the glucuronidation and detoxification of many endogenous or exogenous xenobiotics. Gilbert's syndrome (GS) and Crigler Najjar syndrome type 2 (CNS-II) are characterized by unconjugated hyperbilirubinemia due to reduced enzymatic activity of UGT1A1. Recent studies have demonstrated the frequent co-existence of UGT1A1 *28 (-53 [TA]6>7) with other polymorphisms of UGT1A6 and UGT1A7. This finding suggests the occurrence of linkage disequilibrium (LD) among UGT1A1, UGT1A6 and UGT1A7 polymorphisms. UGT1A1 *6 (211G>A, G71R) and UGT1A1 *28 are common in Asian populations. In the present study, we investigated the LD of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. Exon 1 of UGT1A1, UGT1A6 and UGT1A7 was sequenced using genomic DNA isolated from peripheral leukocytes of 390 Japanese subjects. LD and haplotypes were analyzed using SNPAlyze ver. 5.0 software. UGT1A1 *6 had a strong LD in relation to UGT1A6 variants including 541A>G and 552A>C (D'=0.846-0.848, r(2)=0.413-0.438) and UGT1A7 variants including 387T>G, 391C>A, 392G>A and 622T>C (D'=0.667-0.858, r(2)=0.207-0.413). UGT1A1 *28 had a lower degree of LD than UGT1A1 *6 in relation to these variants (D'=0.245-0.401, r(2)=0.025-0.063). All the haplotypes with G71R lacked -53[TA]6>7. The present study showed for the first time that the LD of UGT1A1 *6 in relation to UGT1A6 and 1A7 polymorphisms is far stronger than UGT1A1 *28. The UGT1A1 *6 allele appears to be independent of the UGT1A1 *28 allele. Although patients with GS and CNS-II are believed to have good prognosis, a subgroup of GS or CNS-II patients with the UGT1A1 *6 polymorphism might be at risk of abnormal drug metabolism and of developing malignant disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969497

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Genome-wide association of serum bilirubin levels in Korean population.

Authors:  Tae-Wook Kang; Hee-Jin Kim; Hyoungseok Ju; Jeong-Hwan Kim; Yeo-Jin Jeon; Han-Chul Lee; Ka-Kyung Kim; Jong-Won Kim; Siwoo Lee; Jong Yeol Kim; Seon-Young Kim; Yong Sung Kim
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

2.  UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal).

Authors:  Paula R Pacheco; Maria J Brilhante; Cristina Ballart; Francesc Sigalat; Helena Polena; Rita Cabral; Claudia C Branco; Luisa Mota-Vieira
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 3.  PharmGKB summary: very important pharmacogene information for UGT1A1.

Authors:  Julia M Barbarino; Cyrine E Haidar; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

4.  A case of concomitant Gilbert's syndrome and hereditary spherocytosis.

Authors:  Hee Jung Lee; Hee Seok Moon; Eaum Seok Lee; Seok Hyun Kim; Jae Kyu Sung; Byung Seok Lee; Hyun Yong Jeong; Heon Young Lee; Young Jae Eu
Journal:  Korean J Hepatol       Date:  2010-09

5.  A genome-wide association study on liver enzymes in Korean population.

Authors:  Ji Yeon Seo; Jong-Eun Lee; Goh Eun Chung; Eunsoon Shin; Min-Sun Kwak; Jong In Yang; Jeong Yoon Yim
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.